Plant Products as Inhibitors of Coronavirus 3CL Protease
Background: The ongoing COVID-19 pandemic has created an alarming situation due to extensive loss of human lives and economy, posing enormous threat to global health security. Till date, no antiviral drug or vaccine against SARS-CoV-2 has reached the market, although a number of clinical trials are...
Saved in:
Main Authors: | Anirban Mandal (Author), Ajeet Kumar Jha (Author), Banasri Hazra (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Plant products for antiviral therapeutics
by: Anirban Mandal, et al.
Published: (2022) -
Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
by: Matteo Pavan, et al.
Published: (2022) -
In silico screening of potential compounds from begonia genus as 3CL protease (3Cl pro) SARS-CoV-2 inhibitors
by: Saipul Maulana, et al.
Published: (2023) -
Inhibition of SARS-CoV 3CL protease by flavonoids
by: Seri Jo, et al.
Published: (2020) -
The prospective role of plant products in radiotherapy of cancer: A current overview
by: Banasri eHazra, et al.
Published: (2012)